1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Development and validation of a patient-reported outcome measure for systemic sclerosis : the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
(
- Contribution to journal › Article
- 2020
-
Mark
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study
(
- Contribution to journal › Article
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article
- 2017
-
Mark
Treatment outcome in early diffuse cutaneous systemic sclerosis : The European Scleroderma Observational Study (ESOS)
(
- Contribution to journal › Article
-
Mark
Update of EULAR recommendations for the treatment of systemic sclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
Brief Report : IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
(
- Contribution to journal › Article
- 2015
-
Mark
Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis.
(
- Contribution to journal › Article